Long Island Wealth Management’s AbbVie ABBV Stock Holding History

Long Island Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$252K	Buy	1,161 +23	+2%	+$5.1K	0.12%	79
2025 Q4	$260K	Buy	1,138 +93	+9%	+$21.2K	0.12%	75
2025 Q3	$242K	Buy	+1,045	New	+$213K	0.12%	77
2025 Q2	–	Sell	-1,008	Closed	-$211K	–	82
2025 Q1	$211K	Buy	+1,008	New	+$196K	0.13%	75
2024 Q1	–	Sell	-953	Closed	-$148K	–	76
2023 Q4	$148K	Buy	+953	New	+$139K	0.11%	83

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Long Island Wealth Management's ABBV Position: Q1 2026 in Review

Long Island Wealth Management increased its AbbVie (ABBV) stake by 2% in Q1 2026, buying an estimated $5.1K and bringing the position to 1,161 shares worth $252K. The position accounts for 0.12% of the portfolio, ranked #79.

Long Island Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 5 quarters since. The position peaked at $260K in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Long Island Wealth Management held 1,161 shares of AbbVie worth $252K as of Q1 2026.
Long Island Wealth Management bought 23 AbbVie shares in Q1 2026, an estimated $5.1K.
AbbVie made up 0.12% of Long Island Wealth Management's portfolio in Q1 2026, its #79 holding.
Long Island Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 5 quarters since.
Long Island Wealth Management's AbbVie position peaked at $260K in Q4 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Long Island Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.